Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent

被引:24
作者
Hamelin, Bettina A. [1 ]
Zakrzewski-Jakubiak, Marcin [2 ]
Robitaille, N. Michelle [1 ]
Bogaty, Peter [1 ]
Labbe, Line [2 ]
Turgeon, Jacques [2 ]
机构
[1] Quebec Heart Inst, Quebec City, PQ, Canada
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
关键词
Myocardial infarction; polymorphism; ACE I/D; age dependent; INSERTION DELETION POLYMORPHISM; CORONARY-HEART-DISEASE; CAPTOPRIL; SYSTEM;
D O I
10.1177/0091270010382420
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The angiotensin-converting enzyme (ACE) gene is a candidate genetic locus for coronary artery disease (CAD). Studies investigating the relationship between the ACE-insertion/deletion (I/D) gene polymorphism and myocardial infarction (MI) have been inconsistent. The authors hypothesized that age may be an important modulating factor in this relationship. ACE-I/D allele and genotype distribution was determined in 3 groups: 104 men with a first MI at a young age (<= 45 years old), 271 healthy young men (<= 30 years old), and 28 healthy elderly men (>65 years old). All participants were French descendants from Quebec City, Canada. Frequency distribution of the ACE alleles and genotypes was similar among the healthy young, the healthy elderly, and the MI patients (P > .05). However, when considering the age at the time of the MI (<= 40, <= 35, or <= 30 years old), a significant age-dependent effect with the prevalence of the ACE-DD genotype was found, as it increased by 22%, 61%, and 157%, respectively, compared with the healthy young group (P < .05). Similar observations were obtained versus the healthy elderly men (P < .05). The ACE-I/D polymorphism seems to be a genetic risk factor for MI in young men and becomes an important modulator of MI risk at a young age.
引用
收藏
页码:1286 / 1292
页数:7
相关论文
共 34 条
[1]  
ABERG G, 1990, J CARDIOVASC PHARM, V15, pS65, DOI 10.1097/00005344-199000155-00010
[2]   Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women [J].
Anderson, JL ;
Carlquist, JF ;
King, GJ ;
Morrison, L ;
Thomson, MJ ;
Ludwig, EH ;
Muhlestein, JB ;
Bair, TL ;
Ward, RH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) :790-796
[3]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[4]   PLASMA-LEVEL AND GENE POLYMORPHISM OF ANGIOTENSIN-CONVERTING ENZYME IN RELATION TO MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
COSTEROUSSE, O ;
TIRET, L ;
POIRIER, O ;
LECERF, L ;
GONZALES, MF ;
EVANS, A ;
ARVEILER, D ;
CAMBOU, JP ;
LUC, G ;
RAKOTOVAO, R ;
DUCIMETIERE, P ;
SOUBRIER, F ;
ALHENC-GELAS, F .
CIRCULATION, 1994, 90 (02) :669-676
[5]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[6]  
CAULFIELD M, 1995, BRIT HEART J, V74, P207
[7]   TISSUE RENIN-ANGIOTENSIN SYSTEM IN MYOCARDIAL HYPERTROPHY AND FAILURE [J].
DZAU, VJ .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (08) :937-942
[8]  
DZAU VJ, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199322005-00002
[9]   ANGIOTENSIN-I CONVERTING ENZYME [J].
ERDOS, EG .
CIRCULATION RESEARCH, 1975, 36 (02) :247-255
[10]  
Espinosa JS, 1998, MED CLIN-BARCELONA, V110, P488